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Abstract P2Y receptor activation causes the release of in-
flammatory cytokines in the bronchial epithelium, whereas
G protein-coupled estrogen receptor (GPER), a novel estrogen
(E2) receptor, may play an anti-inflammatory role in this pro-
cess. We investigated the cellular mechanisms underlying the
inhibitory effect of GPER activation on the P2Y receptor-
mediated Ca2+ signaling pathway and cytokine production in
airway epithelia. Expression of GPER in primary human
bronchial epithelial (HBE) or 16HBE14o- cells was con-
firmed on both the mRNA and protein levels. Stimulation of
HBE or 16HBE14o- cells with E2 or G1, a specific agonist of
GPER, attenuated the nucleotide-evoked increases in [Ca2+]i,
whereas this effect was reversed by G15, a GPER-specific
antagonist. G1 inhibited the secretion of two proinflammatory
cytokines, interleukin (IL)-6 and IL-8, in cells stimulated by
adenosine 5′-(γ-thio)triphosphate (ATPγS). G1 stimulated a
real-time increase in cAMP levels in 16HBE14o- cells, which
could be inhibited by adenylyl cyclase inhibitors. The inhibi-
tory effects of E2 or G1 on P2Y receptor-induced increases in
Ca2+ were reversed by treating the cells with a protein kinase
A (PKA) inhibitor. These results demonstrated that the
inhibitory effects of G1 or E2 on P2Y receptor-mediated
Ca2+ mobilization and cytokine secretion were due to
GPER-mediated activation of a cAMP-dependent PKA path-
way. This study has reported, for the first time, the expression
and function of GPER as an anti-inflammatory component in
human bronchial epithelia, which may mediate through its
opposing effects on the pro‐inflammatory pathway activated
by the P2Y receptors in inflamed airway epithelia.
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Introduction
Estrogen (E2) is an important hormone that protects the lungs
from inflammatory damage.Clinical observations suggested that
reduced E2 levels were associated with greater risks of lung pa-
thologies in menopausal women [19, 36]. However, the detailed
anti-inflammatory role played by E2 and its pathophysiological
mechanism are still unknown. In addition to the classical nuclear
hormone receptors, ERα and ERβ, a novel E2 receptor and a G
protein-coupled estrogen receptor (GPER), were recently identi-
fied [35, 43].Despite the accumulating body of evidence indicat-
ing that the rapid, nongenomic actions of E2 observed in the epi-
thelia are mediated via GPER, few studies have investigated the
specific role of GPER in inflammatory airway diseases [31, 32].
Extracellular nucleotide release and the subsequent activa-
tion of P2Y receptors have been implicated in the pathogene-
sis of several inflammatory lung disorders, such as asthma
[28]. During airway inflammation, damage to the surface ep-
ithelium is due to the secretion of eosinophil-derived, highly
toxic, cationic proteins, such as major basic protein (MBP).
Our recent study demonstrated that when human bronchial
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surface epithelia are chemically damaged by poly-L-arginine
as a surrogate of MBP [10], nucleotides, such as ATP and
UDP, are released into the extracellular medium. The extracel-
lular nucleotides then activate cell surface P2Y receptors to
release two proinflammatory cytokines, interleukin (IL)-6 and
IL-8, via a Ca2+-dependent process [20].
To the best of our knowledge, no reports have determined
whether GPER is expressed in airway epithelia or whether
GPER plays a role in the regulation of P2Y receptor-
mediated Ca2+ signaling and cytokine secretion in airway ep-
ithelia. Therefore, we examined the expression of GPER and
its subcellular localization in human bronchial epithelia. We
also characterized the cross talk between the GPER and P2Y
receptor signaling pathways and its implications on the anti-
inflammatory role of GPER.
Materials and methods
Solutions and chemicals
Krebs-Henseleit (KH) solution and the nominally Ca2+-free
solution were prepared as previously described [24].
Membrane permeant acetoxymethyl (AM) ester forms of
Fura-2 and Pluronic F127 were obtained from Invitrogen
(Carlsbad, USA). Uridine 5′-triphosphate (UTP), uridine 5′-
diphosphate (UDP), adenosine 5′-(γ-thio)triphosphate
(ATPγS), forskolin, poly-L-arginine hydrochloride, SQ
22536, U73122, E2, and G1 were obtained from Sigma-
Aldrich (St. Louis, USA). G15 was obtained from Tocris
(Bristol, UK). H89 dihydrochloride and MDL 12330A were
obtained from Calbiochem (La Jolla, USA). All other general
laboratory reagents were obtained from Sigma-Aldrich, and
all cell culture reagents were obtained from Invitrogen.
Cell culture
The 16HBE14o- cell line was maintained in minimum essen-
tial medium (MEM) supplemented with 10 % fetal bovine
serum, 1 % penicillin/streptomycin, and 1 % glutamine
(Invitrogen, Carlsbad, CA) and cultured as described previ-
ously [47]. In some experiments, MEM with no phenol red
(Invitrogen) was applied. Primary HBE cells were obtained
from ScienCell Research Laboratories (Carlsbad, USA) and
cultured using Bronchial Epithelial Cell Medium (ScienCell
Research Laboratories) following the commercial protocol
described previously [20].
RNA extraction, reverse transcription PCR, and real-time
PCR
Total RNA was extracted with TRIzol Reagent (Invitrogen)
and reverse transcribed to cDNA using iScript™ Reverse
Transcription Supermix (Bio-Rad Laboratories, Hercules,
USA). Reverse transcription PCR (RT-PCR) was performed
with TaKaRa Taq™ DNA polymerase. Real-time PCR was
performed with an Applied Biosystems Power SYBR Green
PCR Master Mix (Invitrogen) on a ViiA™ 7 real-time PCR
system. GPER primer sequences were as follows: forward
primer, 5′-TCTACACCATCTTCCTCTTCC-3′; and reverse
primer, 5′-GTAGCGGTCGAAGCTCATCC-3′. The RT-
PCR products were characterized using 2 % agarose gel elec-
trophoresis. Relative expression of GPER was normalized to
GAPDH and determined with the Pfaffl method [30]. Each
run of PCR included a nontemplate control and a sample
without reverse transcriptase.
Western blotting
Western blotting was performed as described previously [10].
Cells grown in culture dishes were lysed on ice in
Cytobuster™ Protein Extraction Reagent (Merck Millipore,
Billerica, USA), supplemented with a protease inhibitor cock-
tail (no. 78429, Thermofisher Scientific, Waltham, USA) and
a phosphatase inhibitor cocktail (Merck Millipore). Protein
samples (20 μg per lane) were transferred to polyvinylidene
fluoride (PVDF) membranes (Immobilon-P, Merck Millipore)
and immunoblotted with GPER rabbit polyclonal antibody
(N-15)-R (1:500; Santa Cruz Biotechnology, Santa Cruz,
USA). Blocking peptide (sc-38525 P, Santa Cruz
Biotechnology) was used for GPER antibody preabsorption,
andmousemonoclonal antibody toGAPDHwas used as a load-
ing control. All blots were developed using an enhanced chemi-
luminescence detection system (MerckMillipore). The apparent
molecularmasseswere calculatedusingprestained sodiumdode-
cyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE)
midrange protein markers (no. HM0671, Hou-Bio Life
Technologies, HongKong).
Immunofluorescence microscopy
16HBE14o- or primary HBE cells grown on coverslips in
four-well plates were rinsed with phosphate-buffered saline
(PBS) and fixed in 4 % paraformaldehyde for 10 min at room
temperature. Cells were blocked using PBS with 10 % normal
horse serum and 0.1 % Triton X-100 for 1 h and incubated
with GPER (N-15)-R rabbit polyclonal antibody (1:60; sc-
48525-R, Santa Cruz Biotechnology) overnight at 4 °C [13].
After washing, Alexa Fluor® 488 donkey anti-rabbit IgG (H+
L) was added (1:300, Thermofisher Scientific, Waltham,
USA). The coverslips were mounted using mounting medium
with 1.5 μg/ml 4′,6-diamidino-2-phenylindole (DAPI).
Images were captured using a FluoView™-FV1000 confocal
microscope (Olympus, Center Valley, USA). In some experi-
ments, cells were co-incubated with purified mouse anti-E-
cadherin (1:200; no. 610181, BD Biosciences, Heidelberg,
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Germany), purified mouse anti-GM130 (1:200; no. 610823,
BD Biosciences), or KDEL antibody (1:500; NBP1-97469,
Novus Biologicals, Littleton, USA). Alexa Fluor® 555 don-
key anti-rabbit IgG was used for visualization (1:400,
Thermofisher Scientific). For the negative control group,
GPER antibodies were preabsorbed with specific blocking
peptides (sc-48525 P, Santa Cruz Biotechnology).
Small interfering RNA lentivirus packaging
and transduction
Lentiviral transfer vectors containing small interfering RNA
(siRNA)-targeting GPER were purchased from Applied
Biological Materials Inc. (Canada). A lentiviral vector with a
scramble siRNA sequence was used as the negative control.
The VSV-G-pseudotyped lentiviruses were produced by co-
transfecting 293T cells with the transfer vectors and three
packaging vectors, pMDLg/pRRE, pRSV-REV, and pCMV-
VSVG, by calcium phosphate transfection. At 72 h post-trans-
fection, the cell culture supernatant was collected and filtered
through a 0.4-μm filter. The lentivirus was concentrated with
centrifugation at 20,000 rpm and resuspended in 1× Tris-
buffered saline. For lentiviral transduction, 5 × 103 cells were
seeded in 24-well plates, and lentivirus was added to the cells
in the presence of 8 μg/ml hexadimethrine bromide (Sigma-
Aldrich, St. Louis, USA) overnight. After puromycin selec-
tion, the knockdown efficiency of GPER expression was de-
termined by real-time PCR and Western blot analysis.
Measurement of intracellular calcium concentrations
Calcium signals in cells grown on glass coverslips were mea-
sured as previously described [47, 48]. Fura-2 ratios were used
to represent changes in [Ca2+]i using Felix software (Photon
Technology International, Edison, USA ). In Ca2+ imaging ex-
periments, the perfusion chamber was mounted on an inverted
microscope (Olympus IX70, USA) equipped with a scientific
CMOS camera (pco.edge 5.5; PCO AG, Kelheim, Germany).
Images were digitized and analyzed using MetaFluor Imaging
Software (v7.5, Molecular Devices, USA). The data were also
shown quantitatively as a change in Fura-2 ratios.
Manganese quenching
Themanganese quench technique was used to estimate calcium
influx [15, 45]. 16HBE14o- cells were loaded with Fura-2 as
previously described. Since Mn2+ has a similar permeability as
Ca2+ through most plasma membrane Ca2+ channels and
quenches Fura-2 fluorescence at all excitation wavelengths,
Ca2+ influx can be estimated by the Mn2+ quench of Fura-2
fluorescence at the Ca2+-insensitive 360-nm excitation wave-
length. During the measurement, cells were treated with 10-μM
UTP in the absence (nucleotide alone) or presence of E2
(100 nM) or G1 (10 nM) for 10 min. Then 1-mM MnCl2 was
added in perfusion solution to observe the extent of Mn2+ entry.
The rate of Mn2+ quenching was assessed by measuring the
change of slope of Fura-2 fluorescence decrease before and
after the addition of Mn2+ application (using Originlab 8 soft-
ware, Northampton, USA), as well as the percentage decrease
of Fura-2 fluorescence 120 s after Mn2+ application [6, 29, 41].
Monitoring STIM1 oligomerization via FRETmicroscopy
FRET microscopy was used to monitor the dynamic oligo-
merization of stromal interaction molecule 1 (STIM1) in
16HBE14o- cells. Plasmids expressing N-terminally tagged
cyan fluorescent protein (CFP)- and yellow fluorescent pro-
tein (YFP)-STIM1, pEX-SP-CFP-STIM1, and pEX-SP-YFP-
STIM1 were obtained from Addgene (Cambridge, USA).
Cells were incubated in Ca2+-free Hanks’ Balanced Salt
S o l u t i o n (HBSS ) w i t h 4 - ( 2 - hyd r oxye t h y l ) - 1 -
piperazineethanesulfonic acid (HEPES) during imaging ex-
periments. E2, G1, or dimethyl sulfoxide (DMSO) vehicle in
HEPES-HBSSmodified was perfused into the imaging cham-
ber using a perfusion pencil (AutoMate Scientific, Berkeley,
USA) from 0 to 15min, followed by the addition of ATP to the
perfusion solution to deplete Ca2+ in the ER. Images were
captured using a Nikon Eclipse Ti microscope with a
SPOTS RT3 camera (SPOT Imaging Solutions, Sterling
Heights, USA). AnND8 filter was used during the experiment
to reduce photobleaching. Each set of images (CFP, YFP, and
FRET channels) was taken at 0.2 Hz using MetaFluor 7.8
software. The captured images were analyzed with ImageJ
software (NIH, Bethesda, USA) using the pixel-to-pixel com-
parison method [16]. Sensitized emission was employed for
the bleed-through correction. These specific bleed-throughs
were obtained on a pixel-to-pixel basis from cells transfected
with CFP-STIM1 or YFP-STIM1 alone. In our experimental
settings, specific bleed-throughs for CFP and YFP were 0.696
and 0.064, respectively. To reduce photobleaching errors,
NFRET measurements were adopted as described [49].
Quantitative measurement of STIM1 puncta formation
The formation STIM1 puncta after ER Ca2+ depletion by ATP
stimulation was measured as described [18]. In brief,
16HBE14o- cells were transfected with YFP-STIM1
(Addgene, Cambridge, USA). Transfected cells were stimu-
lated with ATP (10 μM) in the absence of extracellular Ca2+ in
HEPES-HBSS solution. Single and isolated cells were select-
ed for analyses. Z-stacks of images were acquired in a
0.225-μm separation. A Z-slice image near the close proxim-
ity to the attachment surface was selected for puncta analysis
(~225 nm thickness) by ImageJ (NIH). YFP puncta were de-
termined by particle analysis plugin, and fluorescent intensity
greater than the background by three standard deviations was
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measured. Those with size less than 0.2 μm2 and greater than
2.5 μm2 were excluded for the analyses. In some experiments,
transfected cells were pretreated with G1 (10 nM) or E2
(100 nM) before stimulation with ATP.
Real-time measurement of cAMP levels
CFP-Epac-YFP, an Epac-based polypeptide FRET reporter
[46], was used to monitor real-time cyclic adenosine
monophosphate (cAMP) changes in 16HBE14o- cells. The
experiments were performed using the MetaFluor Imaging
system (with the FRET module). Cells were transfected with
the Epac-based cAMP sensor and excited at 436-nm wave-
lengths. CFP and YFP images were simultaneously recorded
by the imaging setup equipped with the photometrics DV2
emission splitting system (Photometrics, Tucson, USA) in-
cluding two emission filters (470/30 nm for CFP; 535/30 nm
for FRET). Acquired fluorescence images were background
subtracted, and real-time cAMP levels were represented by
normalizing the CFP/FRET emission ratios as described pre-
viously [20, 24]. Images were digitized and analyzed using
MetaFluor imaging software.
Inositol-1-phosphate measurements
16HBE14o- cells were plated 24 h before the experiment into
24-well culture plates at a concentration of 5 × 104 cells/well.
Agonist-induced inositol-1-phosphate (IP1) accumulation in
16HBE14o- cells was quantified using the Cisbio IP-One kit
(Cisbio Bioassays, Codolet, France) according to the manu-
facturer’s instructions [51].
Quantification of IL-6 and IL-8 secretion
Quantification of IL-6 and IL-8 secretion was performed using
an enzyme-linked immunosorbent assay (ELISA) [10]. Cells
were grown in 24-well culture plates. Cell-free supernatants
were collected from control and treated cells and analyzed
using a commercially available ELISA kit specific for IL-6
(eBioscience, San Diego, USA) and IL-8 (BD Biosciences,
San Diego, USA) according to the manufacturers’ protocols.
All experiments were performed in duplicate.
Statistical analysis
Data were expressed as the mean ± the standard error of the
mean (SEM), and values of n referred to the number of inde-
pendent experiments for each group. Statistical comparisons
between original data were performed using the Student’s t
test and analysis of variance (ANOVA) where appropriate.
P < 0.05 was considered to be statistically significant.
Results
Expression and subcellular localization of GPER
in human bronchial epithelial cells
RT-PCR was performed to assess gper messenger RNA
(mRNA) expression in 16HBE14o- (Fig. 1a) and primary hu-
man bronchial epithelial (HBE; Fig. 1b) cells. The PCR prod-
uct of gper mRNAwas expressed in both cell types (lane 1),
and GPER protein expression was examined by Western
Fig. 1 GPER expression in HBE
cells. a, b Agarose gel
electrophoresis of the gper RT-
PCR product obtained from
16HBE14o- (a) and primary HBE
(b) cells, respectively. Lane 1,
gper PCR product (278 bp); lane
2, RT negative control product;
lane 3,Gapdh housekeeping PCR
product (236 bp); M, DNA
markers (no. 3422A, Takara Bio
Inc., Tokyo, Japan) (n = 3–4). c
GPER protein bands (40 kDa) in
primary HBE cells, 16HBE14o-
cells, and MCF-7 cells (positive
control). d GPER antibody was
blocked by peptide preabsorption.
GAPDH (36 kDa) was used as an
internal control (n = 3)
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blotting. GPER was detected as a single protein band of ap-
proximately 40 kDa in both primary HBE and 16HBE14o-
cells (Fig. 1c). MCF-7 cells were used as a GPER-positive cell
line [3]. Detection of these protein bands was specific, as they
were abolished by prior preabsorption of the antibodies with a
control antigen (Fig. 1d).
Additionally, GPER expression was detected by immuno-
fluorescence in 16HBE14o- cells (Fig. 2a). GPERwas labeled
with an Alexa Fluor 488-conjugated anti-GPER antibody, and
nuclei were visualized by DAPI. There was no overlap be-
tween the GPER and nuclear signals. Moreover, no immuno-
reactivity was observed in sections incubated with GPER an-
tibody preabsorbed with the blocking peptide, indicating that
the GPER staining was specific. Similar immunostaining pat-
terns were observed in primary HBE cells (Fig. 2b).
To further characterize the subcellular localization of
GPER, double immunofluorescence labeling was used to de-
termine possible colocalization between GPER and subcellu-
lar fractions, such as the endoplasmic reticulum (ER), Golgi
apparatus, and plasma membrane, in 16HBE14o- cells
(Fig. 2c). The results showed that GPER did not colocalize
with Golgi (anti-GM130), while there was a very small
amount of overlap between the GPER and the ER (anti-
KDEL). In contrast, partial colocalization was observed be-
tween GPER and the plasma membrane (anti-E-cadherin) in
16HBE14o- cells.
Inhibitory effects of E2 or the GPER agonist, G1,
on nucleotide-induced Ca2+ signaling in HBE cells
Our previous study showed that P2Y receptors were expressed
in airway epithelia and could be stimulated by nucleotides,
such as ATP, UTP, and UDP, resulting in an increase in
[Ca2+]i [47]. Because it has been suggested that E2 inhibits
the P2Y receptor-dependent Ca2+ signaling pathway [11], we
examinedwhether activation of GPER had a similar inhibitory
effect on P2Y receptor-mediated increases in Ca2+. In this
study, both 16HBE14o- (Fig. 3a–d) and primary HBE
(Fig. 3e–h) cells were treated with 100-nM E2 or 10-nM G1
for 10 min before being activated by 10-μM UTP (P2Y2 and
P2Y4 agonist), 100-μM UDP (P2Y6 agonist), or 10-μM
ATPγS (P2Y2 and P2Y11 agonist) [1]. The nucleotide-
evoked increases in Ca2+ were inhibited by E2 and G1 with
the percentages of inhibition, varying from 37.0 to 62.4 %.
Both E2 and G1 were dissolved in DMSO, with a stock con-
centration 1000-fold higher than the final concentration.
DMSO alone was used as vehicle control in all relevant ex-
periments and did not produce any significant effect. Similar
findings were obtained in primary HBE cells. The degree of
G1-mediated inhibition of UTP-, UDP-, and ATPγS-induced
increases in Ca2+ were 46.4, 53.4, and 54.6 %, respectively.
Various concentrations of E2 and G1 were used to examine
their inhibitory effects on P2Y receptor-mediated Ca2+
signaling in 16HBE14o- cells. The 16HBE14o- cells were
pretreated with E2 (1–300 nM) or G1 (0.01–100 nM) for
10 min and then stimulated by 10-μM UTP in the presence
of E2 or G1. Both E2 and G1 inhibited the UTP-induced in-
creases in Ca2+ in a concentration-dependent manner (Fig. 3i,
j). The half maximal inhibitory concentration (IC50) values of
E2 and G1 were 12.42 and 0.58 nM, respectively.
To confirm the specificity of the GPER-mediated inhibito-
ry effect of G1, a newly developed GPER antagonist, G15
[14], was used. The 16HBE14o- cells were treated with 10-
nM G1 in the presence or absence of 1-μM G15 for 10 min.
The cells were then stimulated with 10-μM UTP. In the pres-
ence of G15, the inhibitory effect of G1 on the nucleotide-
induced increase in Ca2+ was reversed in both 16HBE14o-
(Fig. 4a) and primary HBE (Fig. 4b) cells. Furthermore, the
inhibitory effect of E2 (100 nM) on the increase in Ca
2+ was
also reversed in the presence of G15 (Fig. 4c), indicating that
E2 could inhibit nucleotide-induced Ca
2+ signaling via GPER.
In addition to using a specific antagonist, we also used
lentiviral vectors expressing siRNA to downregulate the
GPER gene in 16HBE14o- cells. The knockdown efficiency
of GPERwas examined on both the mRNA and protein levels
(Fig. 4d, e). The expression level of GPER in 16HBE14o-
cells transfected with siRNA targeting GPER (siGPER) was
43.9 % lower than those transfected with a negative control
siRNA encoding a scrambled sequence (SCR; Fig. 4f). The
presence of GFP did not disturb Fura-2 fluorescence during
the measurement of [Ca2+]i [5]. The successfully transfected
cells were selected for calcium measurements. The data show
that 10-nMG1 inhibited UTP-induced increases in Ca2+ in the
SCR control group (Fig. 4g), whereas no significant inhibitory
effect was observed in the siGPER group treated with G1
(Fig. 4h, i). These results indicate that the inhibitory effect of
G1 was mediated by GPER.
Effects of E2 and G1 on nucleotide-induced Ca
2+ release
and influx
Intracellular increases in calcium could result from the release
of ER stores or influx through store-operated calcium (SOC)
channels regulated by stromal interaction molecule 1 (STIM1)
[26]. To examine the effects of E2 and G1 on P2Y receptor-
activated intracellular Ca2+ release (first phase) and influx
(second phase), epithelia were exposed to Ca2+-free solution
in the presence or absence of G1 or E2 for 10 min and then
stimulated with UDP or UTP together with G1 or E2.
Subsequently, Ca2+ (2.5 mM) was added back to the perfusate
to induce Ca2+ influx. Typical recordings of fluorescence ra-
tios in control (Fig. 5a) and E2-treated (Fig. 5b) cells show that
both 100-nM E2 and 10-nM G1 inhibited UDP (100 μM)-
induced Ca2+ release in 16HBE14o- cells (Fig. 5c).
However, only E2 inhibited UDP (100 μM)-induced Ca
2+
influx (Fig. 5d). Moreover, the inhibitory effect of 10-nM
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G1 on UDP (100 μM)- or UTP (10 μM)-induced Ca2+ release
(first phase) was reversed by 1-μM G15 (Fig. 5e). Taken to-
gether, these data demonstrate that E2 inhibited nucleotide-
induced Ca2+ release and Ca2+ influx, whereas the GPER
agonist, G1, only inhibited P2Y receptor-mediated Ca2+
release.
The manganese quench technique was also applied to re-
port calcium influx through plasma membrane channels. The
quenching of Fura-2 fluorescence by Mn2+ was measured at
the Ca2+-independent excitation wavelength of Fura-2
(360 nm). When preincubating the cells with 100-nM E2 for
10 min, the rate of change on Mn2+ quenching was signifi-
cantly decreased compared to untreated or G1 pretreated
16HBE14o- cells (Fig. 5f, g). Similarly, the percentage de-
crease of Fura-2 fluorescence 120 s after Mn2+ application
also dropped significantly in E2 pretreated cells but not in
G1 pretreated cells (Fig. 5h). These results indicate that E2,
but not G1, blocked calcium influx through the plasma
membrane.
Calcium release from the ERmainly occurs via inositol 1,4,
5-trisphosphate receptors (IP3R) in human airway epithelial
cells, including 16HBE14o- cells [40]. The activation of var-
ious subtypes of P2Y receptors causes an increase in Ca2+ via
the phospholipase C (PLC)-IP3 signaling cascade [25].
Because the lifetime of IP3 within the cell before it is trans-
formed into IP2 and IP1 is very short, IP1 accumulation levels
can be used to represent IP3 levels in cells. To induce IP1
accumulation by activating the P2Y receptor-mediated signal-
ing pathway in 16HBE14o- cells, 10-μM UTP (Fig. S1a) or
100-μM UDP (Fig. S1b) was used. Dimethyl sulfoxide
(DMSO), the solvent used for E2 and G1, did not affect IP1
accumulation. UTP- or UDP-induced IP1 could be blocked by
U73122 (10 μM), an inhibitor of PLC, whereas E2 (10 and
100 nM) or G1 (10 nM) had no effect on UTP- or UDP-
induced IP1 accumulation.
The effects of E2 and G1 on SOC influx was determined by
fluorescence resonance energy transfer (FRET) using
16HBE14o- cells co-expressing CFP- and YFP-STIM1.
STIM1 proteins are known to undergo oligomerization in re-
sponse to Ca2+ depletion in the ER [21]. The addition of ATP
triggered Ca2+ release from the ER in 16HBE14o- cells, lead-
ing to the oligomerization of CFP- and YFP-STIM1, thus
generating FRET signals (Fig. 6a). In controls and in cells
pretreated with 10-nM G1, the addition of ATP elicited ap-
proximately a 20 % increase in NFRET, whereas in cells
pretreated with 100-nM E2, the ATP-induced NFRET signal
was significantly attenuated (Fig. 6a, b). Prominent increase
in FRET signal was observed due to the oligomerization and
translocation of STIM1 near the plasma membrane in control
and G1 pretreated 16HBE14o- cells (Fig. 6c). However, the
FRET signal was greatly reduced in cells pretreated with E2
compared to controls and G1 pretreated cells (Fig. 6c). To
further investigate that the increase in FRET signal was due
to oligomerization of STIM1, we measured STIM1 puncta
formation in response to ATP stimulation in the absence of
extracellular Ca2+. Addition of ATP to control 16HBE14o-
cells transfected with YFP-STIM1 generated significant
amount of STIM1 puncta dots (Fig. 6d, e). ATP induced a
comparable amount of STIM1 puncta formation in cells
pretreated with 10-nM G1 (Fig. 6d, e). However, the STIM1
puncta formation was significantly reduced in cells pretreated
with 100-nM E2 (Fig. 6d, e). Taken together, these results
suggest that E2 attenuates SOC by inhibiting STIM1
oligomerization.
E2- and G1-induced cAMP production
GPER activation may initiate the cAMP and protein kinase A
(PKA) signaling pathways [50]. Thus, real-time cAMP levels
were monitored in 16HBE14o- cells stimulated by G1. After
the addition of 10-nM G1 to 16HBE14o- cells, the cAMP
levels increased (Fig. 7a). This stimulatory effect of G1 on
cAMP levels was blocked by the GPER antagonist, G15
(Fig. 7b), indicating that the effect was specific. Similarly,
E2 (100 nM) also induced an increase in cAMP levels (change
in emission ratio = 0.12 ± 0.02, n = 5). When the cells were
treated with 1-μM G15 for 10 min before the addition of
various concentrations of G1, cAMP production was signifi-
cantly inhibited compared to G1 alone.
To demonstrate the involvement of adenylyl cyclase (AC)
in cAMP production, two AC inhibitors, MDL 12330A and
SQ 22536, were used. G1-induced cAMP production was
significantly inhibited by 10-min treatments with MDL
12330A (0.1, 1, and 10 μM) in a concentration-dependent
manner (Fig. 7c). Similar results were obtained with SQ
22536 (Fig. 7d). These results suggest that GPER is coupled
to the activation of AC, likely via the Gs alpha subunit, to
stimulate an increase in cAMP levels in 16HBE14o- cells.
The role of PKA in E2- and G1-mediated inhibition
of calcium increases
We next determined whether the cAMP-dependent pathway
was involved in the inhibitory effects of E2 and G1 on the
P2Y-induced increase in Ca2+ in 16HBE14o- cells. H89, a
Fig. 2 GPER localization in HBE cells. a 16HBE14o- cells immuno-
stained with GPER antibody (sc-48525 N-15; green) and DAPI (nuclei;
blue) (upper row). Bright-field photomicrograph shows the same field
and cells. 16HBE14o- cells immunostained with GPER antibody
preabsorbed with blocking peptide (lower row). Scale bar, 10 μm. b
Similar GPER immunostaining results using primary HBE cells. Scale
bar, 20 μm. c 16HBE14o- cells immunostained with GPER antibody and
the ER marker, KDEL (upper row), the Golgi apparatus marker, GM130
(middle row), or the plasma membrane marker, E-cadherin (lower row).
Blue, DAPI, nuclei. Scale bar, 10 μm. Images are representative of three
to five independent experiments. (Color figure online)
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PKA inhibitor, was used to inhibit downstream signaling tar-
gets of cAMP. The inhibitory effects of G1 (10 nM) on 10-μM
UTP- or 100-μM UDP-induced increases in Ca2+ were re-
versed by co-incubation of the cells with H89 (10 μM) for
10 min (Fig. 7e). Similar results were obtained with 100-nM
E2 (Fig. 7f). These results demonstrate that the inhibitory ef-
fects of E2 and G1 on P2Y receptor-induced Ca
2+ signaling
are mediated via the activation of a cAMP-dependent PKA
pathway.
Effects of the GPER agonist, G1, on nucleotide-
or poly-L-arginine-induced cytokine production in HBE
cells
Our previous study indicates that the levels of two proinflam-
matory cytokines, interleukin 8 (IL-8) and IL-6, increase sig-
nificantly after airway bronchial epithelial cells are stimulated
by extracellular nucleotides when the cells are damaged by
poly-L-arginine [20]. Therefore, the effects of G1 on
nucleotide- or poly-L-arginine-induced IL-8 and IL-6
production were determined in HBE cells. ATPγS (10 μM)
or poly-L-arginine (3 μM) was incubated with the cells for 6 h
in the presence or absence of G1 (10 nM). Significant inhibi-
tion of ATPγS- or poly-L-arginine-stimulated IL-8 release was
observed under these conditions (Fig. 8a, b). The addition of
10-nM G1 also showed a significant inhibitory effect on
ATPγS-stimulated IL-6 release in 16HBE14o- cells
(Fig. 8c). These results indicate that GPER may play an im-
portant role in inhibiting proinflammatory cytokine secretion
stimulated by P2Y receptor activation in HBE cells.
Discussion
GPERisknowntoplayimportant roles inmultiple tissues, includ-
ing the heart, brain, lung, liver, skeletal muscle, and kidney [33].
However, fewreportshavedescribed the expressionand function
of GPER in airway epithelial cells. Only one study described the
relativelyhigh expressionofGPER inhumannonsmall cell, lung
cancercell linescompared to immortalizednormal lungbronchial
Fig. 3 Inhibitory effects of E2 or G1 on nucleotide-induced increases in
Ca2+ in HBE cells. 16HBE14o- (n = 4–6) were stimulated with 10-μM
UTP (a), 100-μM UDP (b), or 10-μM ATPγS (c) in the absence (nucle-
otide alone) or presence of E2 (100 nM) orG1 (10 nM) for 10min, and the
maximal increase in the Fura-2 fluorescence ratio was quantified. d
Statistical results for a to c. Similarly, primary HBE cells (n = 4–7) were
stimulated with 10-μMUTP (e), 100-μMUDP (f), or 10-μMATPγS (g)
in the absence (nucleotide alone) or presence of G1 (10 nM) for 10 min,
and h shows the summarized data. i, j UTP-induced Ca2+ increases in
16HBE14o- cells were inhibited in a concentration-dependent manner by
E2 (i) or G1 (h) (n = 3–8). Data are expressed as the mean ± SEM. *P <
0.05, **P < 0.01, and ***P < 0.001 compared to nucleotide alone
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epithelial cells [23]. This study therefore reports for the first time
the expression and function of GPER as an anti-inflammatory
component in human bronchial epithelia and highlights that
GPER likely serves this role through its opposing effects on the
proinflammatory pathway activated by the P2Y receptors in in-
flamed airway epithelia.
The mRNA and protein expression levels of GPER in pri-
mary HBE and 16HBE14o- cells were confirmed by RT-PCR
and Western blotting, respectively. Although GPER localizes
to the ER [35] and plasma membrane [17], its subcellular
localization is still controversial. Overall, the localization of
GPER appears to vary depending on the cell type. Our immu-
nofluorescence studies showed partial colocalization between
the GPER and the plasma membrane with no overlap between
GPER and Golgi, or nucleus. Besides, a very small amount of
GPERwas localized in ER. These results were similar to those
observed in osteocyte-like MLO-Y4 cells and transfected
HEK-293 cells [17, 34]. Different tissues or cell types may
have different subcellular GPER localizations, which may be
due to the different roles GPER plays in various cell types,
such as cell proliferation, apoptosis, and immune responses
[27]. However, it should be noted that, even in the same cells,
GPER could change its location via endocytotic processes.
Two reports have demonstrated that GPER can be trafficked
intracellularly from the plasmamembrane [8, 38]. This unique
mechanism could decrease the amount of GPER at the plasma
Fig. 4 Reversal of E2- and G1-inhibited increases in Ca
2+ via the GPER
antagonist, G15, or GPER siRNA knockdown in HBE cells. a G15
(1 μM) reversed the inhibitory action of G1 (10 nM) on UTP (10 μM)-,
UDP (100 μM)-, and ATPγS (10 μM)-induced increases in Ca2+ in
16HBE14o- cells (n = 4–5). b Similar results were obtained in primary
HBE cells (n = 3–7). c G15 (1 μM) reversed the inhibitory effect of E2
(100 nM) on UTP (10 μM)- and UDP (100 μM)-induced increases in
Ca2+ in 16HBE14o- cells (n = 4–6). d real-time PCR analyses of GPER
expression in 16HBE14o- cells transfected with siRNA targeting GPER
(siGPER) or scramble siRNA (SCR) (n = 5). e Protein band of GPER in
16HBE14o- cells transfected with siGPER or SCR. GAPDH was used as
internal control (n = 4). f GFP and Fura-2 fluorescence in 16HBE14o-
cells transfected with GFP-tagged siRNA. Fura-2 fluorescence intensity
indicates Ca2+ density. g–i 16HBE14o- cells transfected with SCR or
siGPER were stimulated with 10-μM UTP in the presence or absence
of G1 (10 nM) for 10 min, and the maximal increase in the Fura-2 fluo-
rescence ratio was quantified (n = 14–23 experiments in individual cells).
Data are expressed as the mean ± SEM. *P < 0.05, **P < 0.01, and ***P
< 0.001 compared to nucleotide alone
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membrane and protect cells from chronic signaling. Thus, we
could not exclude this possibility, but the exact details of this
intriguing membrane receptor trafficking pathway in human
bronchial epithelia require further study.
In this study, activation of GPER by G1 did not alter basal
[Ca2+]i levels, but it did significantly inhibit P2Y receptor-
mediated increases in Ca2+. This inhibitory effect was not
P2Y receptor subtype-specific, because G1 inhibited the
Fig. 5 Inhibitory effects of E2 and G1 on the two phases of nucleotide-
induced Ca2+ increase. a, b Representative recordings of Fura-2 fluores-
cence ratios in control (a) and E2-treated (b) cells. 16HBE14o- cells were
superfused with nominally Ca2+-free solution for 10 min in the absence
(control) or presence of E2 (100 nM) and then exposed to UDP (100 μM).
Once [Ca2+]i had returned to basal levels, external Ca
2+ was subsequently
restored (2.5 mM). c, d The inhibitory effect of E2 (c; 100 nM) and G1 (d;
10 nM) on UDP (100 μM)-induced Ca2+ release (first phase) and Ca2+
influx (second phase) in 16HBE14o- cells, respectively (n = 6–9). e Cells
were stimulated with nucleotide (UTP or UDP) alone or in the presence of
G1 (10 nM) with or without G15 (1 μM), and Ca2+ release (first phase)
was quantified by Fura-2 fluorescence microscopy (n = 4–8). f–h
Representative recordings and quantification of Mn2+ quenching of
Fura-2 fluorescence. 16HBE14o- cells preincubated with E2 (100 nM)
or G1 (10 nM) were stimulated with 10-μMUTP for 5 min before adding
Mn2+ (1 mM). In f, maximal fluorescence (360 nmwavelength) was set to
100 % and fluorescence quench was measured 120 s after Mn2+ applica-
tion. g Compiled data showing the percentage of fluorescence decrease
120 s after addingMn2+ in cells treated with UTP alone or in the presence
of E2 or G1. h Summarized data showing the change in slope before and
after Mn2+ application. Data are expressed as themean ± SEM. *P < 0.05,
**P < 0.01, and ***P < 0.001 compared to nucleotide alone
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Ca2+ responses elicited by different P2Y receptor subtype li-
gands (e.g., UTP, UDP, and ATPγS). The inhibitory effect
could be reversed when pretreating with GPER-specific an-
tagonist, G15. Besides, siRNA knockdown of GPER was also
applied to further confirm the role of GPER. Various transfect
reagents (e.g., lipofectamine 2000, lipofectamine RNAiMax,
siPORT NeoFX, DharmaFECT 1 and 4) have been applied in
our experiment for GPER silencing; however, the knockdown
Fig. 6 E2 impairs STIM1 oligomerization during Ca
2+ depletion from
the ER. a Time course of changes in NFRET in 16HBE14o- cells co-
transfected with CFP- and YFP-STIM1. Cells were pretreated with 10-
nM G1 or 100-nM E2 in Ca
2+-free HEPES-HBSS for 15 min. Cells
pretreated with DMSO vehicle were used as controls (CTRL). Ca2+ from
the ER was depleted by the addition of 10-μM ATP at t = 15 min. The
experiment was repeated five times, and NFRET of the cells was normal-
ized to its initial value. b Statistical analysis of the changes inNFRETat t =
20 min using one-way ANOVA with Tukey’s multiple comparison test,
**P < 0.01. c Representative micrographs highlighting STIM1 localiza-
tion before (t = 15 min) and after (t = 0 min) Ca2+ depletion from the ER.
Images were captured in the CFP (upper panel) and FRET (lower panel)
channels. Scale bar, 10 μm. d Representative confocal images depict the
formation of YFP-STIM1 puncta in 16HBE14o- cells after ER Ca2+ was
depleted by ATP. Cell were pretreated with DMSO (CTRL), 10-nM G1,
or 100-nM E2 in Ca
2+-free HEPES-HBSS for 15 min followed by ER
Ca2+ depletion induced with 10-μM ATP. e STIM1 puncta were deter-
mined by ImageJ, and the amount of STIM1 puncta was summarized as
mean ± SEM from six isolated cells obtained from three individual ex-
periments of each treatment. Images were taken in ×60 oil immersion
objective, and the scale bar represents 10 μm
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efficiency was low and inconsistent (data not shown).
Therefore, lentiviral-mediated silencing approach was
adopted and a stable silenced cell line was generated with
better knockdown efficiency on GPER. To reveal whether
G1 inhibited intracellular increases in Ca2+ by blocking Ca2+
release and/or Ca2+ influx, we characterized the two phases of
Ca2+ increase by perfusing cells with a Ca2+-free Krebs-
Henseleit Buffer, followed by a Ca2+-containing solution.
The results showed that E2 inhibited both P2Y receptor-
mediated Ca2+ release and Ca2+ influx, whereas G1 only
inhibited Ca2+ release. However, the observed difference in
Ca2+ signals could be due to regulation of Ca2+ pumps. The
inhibitory effect of E2 onCa
2+ influxwas further confirmed by
the data obtained from Mn2+ quench experiments. Taken to-
gether, these data suggest that the activation of GPER only
inhibits P2Y-activated IP3-mediated Ca
2+ release, whereas
classical E2 receptors activated by E2 played a role in regulat-
ing Ca2+ influx. FRET microscopy further confirmed that the
inhibitory effect of E2, but not G1, on SOC influx was due to
the inhibition of STIM1 oligomerization. Our findings were
similar to those reported recently [39], which showed that E2
can signal nongenomically by inhibiting basal phosphoryla-
tion of STIM1, leading to a reduction of SOC entry in human
airway cells.
The inhibition of Ca2+ release by G1 could occur via dif-
ferent pathways. For example, GPER activation might block
the activity of PLCβ to diminish the synthesis of IP3, inhibit
the activity of IP3R to release Ca
2+ from ER, or stimulate Ca2+
uptake into stores by activating the endoplasmic Ca2+-ATPase
pump. To investigate the detailed mechanism underlying the
Fig. 7 G1-stimulated cAMP
mobilization and inhibition of
increases in Ca2+ via cAMP-
dependent PKA signaling in
16HBE14o- cells. a Real-time
cAMP changes (represented by
normalized CFP/FRET emission
ratios) recorded in 16HBE14o-
cells stimulated with G1 (10 nM).
b 16HBE14o- cells were
stimulated with different
concentrations of G1 (1, 10, and
100 nM) alone or in the presence
of G15 (1 μM). G15 was added
10 min before the addition of G1.
Forskolin (25 μM) was used as a
positive control to stimulate a
maximal increase in cAMP levels
(n = 4–8). c, d 16HBE14o- cells
were treated with the adenylyl
cyclase inhibitors, MDL 12330A
or SQ 22536 (0.1, 1, and 10 μM),
for 10 min followed by
stimulation of the cells with G1
(10 nM) (n = 4–6). e, f Cells were
treated with E2 (100 nM) or G1
(10 nM) in the presence or
absence of the cAMP-dependent
PKA inhibitor, H89 (10 μM), for
10 min, followed by stimulation
of the cells with UTP (10 μM) or
UDP (100 μM) (n = 3–5). Data
are expressed as the mean ± SEM.
*P < 0.05, **P < 0.01, and
***P < 0.001 compared to G1 or
nucleotide alone
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inhibitory effects of E2 and G1 on P2Y receptor-mediated
Ca2+ mobilization, we conducted another series of studies to
examine whether E2 or G1 could inhibit IP3 production. We
measured IP1 accumulation to determine IP3 levels. IP1 accu-
mulation induced by both UDP and UTP was significantly
inhibited by the PLC inhibitor, U73122, whereas the addition
of E2 or G1 showed no inhibitory effects. This result indicates
that the E2- or G1-mediated inhibition of P2Y receptor-
mediated Ca2+ signaling was not related to a change in IP3
levels. Thus, the observed inhibition may be due to the inhi-
bition of IP3 independent of Ca
2+ release. Alternatively, it may
be due to an unidentified signaling pathway or molecule that
interferes with the interaction between IP3 and IP3R [2].
GPER couples to different signaling pathway(s), including
the cAMP/PKA pathway [50]. Our data suggest that GPER in
human bronchial epithelia was coupled to AC, resulting in an
increase in cAMP levels. Notably, blocking the downstream
target of cAMP with H89 reversed the inhibitory effect of G1
on P2Y receptor-mediated Ca2+ signaling, and cAMP-
dependent protein kinase reportedly inhibits IP3-induced
Ca2+ release in human bone marrow cells [42]. The cAMP/
PKA pathway may inhibit receptor-operated calcium entry
(ROCE) via transient receptor potential canonical channel 6
(TRPC6). TRPC6 is expressed in both undifferentiated and
differentiated primary HBE cells [12]. Calcium influx medi-
ated by TRPC6 is functionally coupled to calcium-activated
chloride channel activity in human airway epithelial cells [4]
and can be regulated by P2Y receptor activation in mouse
podocytes [37]. A recent study suggests that the cAMP/PKA
signaling pathway can inhibit endothelin type A receptor-
mediated ROCE via TRPC6 by phosphorylation of Ser28 site
in human embryonic kidney 293 cells [22]. Although G1 did
Fig. 8 G1 inhibited nucleotide-stimulated IL-8 and IL-6 release in
16HBE14o- cells. a–c 16HBE14o- cells were treated with ATPγS (a, c;
10 μM) or poly-L-arginine (b; 1 μM) for 6 h in the presence or absence of
G1 (10 nM). The supernatant was then collected, and IL-8 or IL-6 was
quantified using an ELISA kit. The levels of IL-6 and IL-8 were corrected
against vehicle control alone and expressed as the net release. Data are
expressed as the mean ± SEM. *P < 0.05 compared to ATPγS or poly-L-
arginine alone (n = 3–8). d Schematic diagram showing the GPER func-
tion in regulating P2Y receptor-mediated Ca2+ signaling and cytokine
secretion in human bronchial epithelia. In HBE cells, nucleotides, such
as UTP, UDP, and ATP, activate P2Y receptors to modulate intracellular
increases in Ca2+, which lead to the release of proinflammatory cytokines,
such as IL-8 and IL-6. Activation of GPER by E2 or its specific agonist,
G1, attenuates both the nucleotide-evoked increases in Ca2+ and the cy-
tokine secretion. This inhibitory effect is likely due to the activation of a
GPER-mediated cAMP/PKA pathway. Note that whether G1 and E2 can
translocate through the plasma membrane to act on the receptor that needs
to be verified
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not have any significant effect on nucleotide-mediated Ca2+
influx, we did not explicitly examine P2Y receptor-mediated
ROCE in this study. It would be interesting for future research
to examine if GPR30 can inhibit P2Y receptor-mediated
ROCE via TRPC6 in human airway epithelia. In addition to
PKA, Epac is another downstream target of cAMP that trans-
duces diverse cellular actions [7, 9]. The cAMP increases
evoked by G1 are sufficient to activate Epac. Interestingly,
our previous study demonstrates that both Epac 1 and Epac
2 are expressed in 16HBE14o- cells [24]. Therefore, we could
not exclude the possibility that some of the observed inhibi-
tory effects were mediated through activation of Epac.
Moreover, our recent study demonstrates that the proin-
flammatory effect of nucleotides is mediated via an in-
crease in [Ca2+]i after P2Y receptor activation. Treating
16HBE14o- cells with the intracellular Ca2+ chelator,
BAPTA-AM, but not H89, inhibited P2Y receptor-
mediated IL-6 and IL-8 secretion [20]. Taken together,
GPER likely inhibits the P2Y receptor-mediated inflamma-
tory response by downregulating [Ca2+]i in human airway
epithelia. A recent study reported that Ca2+-dependent cal-
modulin can regulate GPER-dependent signaling at the
receptor level [44]. Therefore, a P2Y receptor-mediated
increase in Ca2+ could, in turn, regulate GPER function,
but the details of the possible cross talk between the two
receptors require further investigation. 16HBE14o- cells
were cultured in MEM without phenol red in some exper-
iments since phenol red may serve as a weak estrogen
mimic. However, no significant differences have been ob-
served in terms of GPER expression and the inhibitory
effect of G1 on P2Y receptor-mediated cytokine secretion
and Ca2+ increase (data not shown) in cells cultured in
MEM with or without phenol red.
In summary, this study characterizes the expression, local-
ization, and role of GPER, as well as its interaction with P2Y
receptors, that were co-expressed in human bronchial epithe-
lia. Activation of GPER by E2 or its specific agonist, G1,
rapidly attenuated a nucleotide-evoked increase in Ca2+,
whereas the specific GPER antagonist, G15, reversed this
GPER-mediated inhibition. Furthermore, E2 and G1 also
inhibited nucleotide-induced cytokine release. The inhibitory
effects on P2Y receptor-mediated Ca2+ mobilization and cy-
tokine secretion are likely due to GPER-mediated activation
of a cAMP-dependent PKA pathway in human bronchial ep-
ithelia (Fig. 8d).
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